Respiratory Profile, Region 16, Inland Northwest (OR, Central and Eastern WA), Serum
Use
This test is useful for assessing sensitization to various inhalant allergens commonly found in the inland Northwest region, including Oregon and central and east Washington. It helps to define the allergen responsible for eliciting signs and symptoms and identify allergens responsible for allergic responses or anaphylactic episodes. Additionally, it assists in confirming sensitization prior to immunotherapy and investigating the specificity of allergic reactions to insect venom, drugs, or chemical allergens.
Special Instructions
For a listing of allergens available for testing, refer to Allergens - Immunoglobulin E (IgE) Antibodies PDF. Complete, print, and send an Allergen Test Request form with the specimen if not ordering electronically.
Limitations
The test is not useful for patients previously treated with immunotherapy to determine if residual clinical sensitivity exists, or in those whose medical management does not depend on the identification of allergen specificity. Furthermore, elevated concentrations of total IgE must be interpreted in the clinical context as they do not solely indicate allergic disease.
Methodology
Immunoassay (Fluorescence Enzyme Immunoassay (FEIA))
Biomarkers
LOINC Codes
- 51991-8
- 15284-3
- 6020-2
- 6025-1
- 15283-5
- 7155-5
- 6833-8
- 6178-8
- 53760-5
- 6078-0
- 6090-5
- 6095-4
- 6098-8
- 6096-2
- 6109-3
- 19113-0
- 6183-8
- 6189-5
- 6212-5
- 6233-1
- 6234-9
- 6244-8
- 6265-3
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.6 mL
Minimum Volume
1.4 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis OK, Gross lipemia OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |
